Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 2, 2013, Pages 220-226

  Bohm D ^a   Stock Gissendanner, S ^a,b   Bangemann, K ^a,b   Snitjer, I ^c   Werfel, T ^d   Weyergraf, A ^e   Schulz, W ^f   Jager B ^d   Schmid Ott, G ^a,b  

^a Institute for Innovative Rehabilitation   (Germany)

^b Berolina Clinic   (Germany)

^c Hans Susemihl Hospital   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e Dermatology Unit of the Specialist Clinic Bad Bentheim   (Germany)

^f TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; SELF ESTEEM; SEX DIFFERENCE; SHORT FORM 8; SKIN DISCOMFORT;

FEMALE; HUMANS; MALE; PSORIASIS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STEREOTYPING;

EID: 84872675767     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04451.x     Document Type: Article

References (30)

1. McKenna KE, Stern RS,. The outcomes movement and new measures of the severity of psoriasis. J Am Acad Dermatol 1996; 34: 534-538.
2. Stern RS, Nijsten T, Feldman SR, et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136-139.
3. Vardy D, Besser A, Amir M, et al. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients 4. Br J Dermatol 2002; 147: 736-742.
4. Katsambas A,. Quality of life in dermatology and the EADV. J Eur Acad Dermatol Venereol 1994; 3: 211-214.
5. Perrott SB, Murray AH, Lowe J, Mathieson CM,. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization 27. Physiol Behav 2000; 70: 567-571.
6. Misery L, Thomas L, Jullien D, et al. Comparative study of stress and quality of life in outpatients consulting for different dermatoses in 5 academic departments of dermatology. Eur J Dermatol 2008; 18: 412-415.
7. Russo PA, Ilchef R, Cooper AJ,. Psychiatric morbidity in psoriasis: a review. Australas J Dermatol 2004; 45: 155-159.
8. Weiss SC, Kimball AB, Liewehr DJ, et al. Quantifying the harmful effect of psoriasis on health-related quality of life 5. J Am Acad Dermatol 2002; 47: 512-518.
9. Augustin M, Kruger K, Radtke MA, et al. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology 2008; 216: 366-372.
10. de Jager ME, van de Kerkhof PC, de Jong EM, Seyger MM,. A cross-sectional study using the Children's Dermatology Life Quality Index (CDLQI) in childhood psoriasis: negative effect on quality of life and moderate correlation of CDLQI with severity scores. Br J Dermatol 2010; 163: 1099-1101.
11. Ashcroft DM, Wan Po AL, Williams HC, Griffiths CE,. Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol 1999; 141: 185-191.
12. Menter A, Kosinski M, Bresnahan BW, et al. Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis 3. J Drugs Dermatol 2004; 3: 27-38.
13. Schmid-Ott G, Malewski P, Kreiselmaier I, Mrowietz U,. Psychosocial consequences of psoriasis-an empirical study of disease burden in 3753 affected people. Hautarzt 2005; 56: 466-472.
14. Ljosaa T, Mork C, Stubhaug A, et al. Skin pain and skin discomfort is associated with quality of life in patients with psoriasis. J Eur Acad Dermatol Venereol 2012; 26: 29-35.
15. Reich A, Hrehorow E, Szepietowski JC,. Pruritus is an important factor negatively influencing the well-being of psoriatic patients 5. Acta Derm Venereol 2010; 90: 257-263.
16. Hrehorow E, Salomon J, Matusiak L, et al. Patients with psoriasis feel stigmatized. Acta Derm Venereol 2011; 92: 67-72.
17. Gupta MA, Gupta AK, Watteel GN,. Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders. Cutis 1998; 61: 339-342.
18. Richards HL, Fortune DG, Griffiths CE, Main CJ,. The contribution of perceptions of stigmatisation to disability in patients with psoriasis 26. J Psychosom Res 2001; 50: 11-15.
19. Schmid-Ott G, Jaeger B, Kuensebeck HW, et al. Dimensions of stigmatization in patients with psoriasis in a 'Questionnaire on Experience with Skin Complaints' 31. Dermatology 1996; 193: 304-310.
20. Ginsburg IH, Link BG,. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989; 20: 53-63.
21. Schmid-Ott G, Kunsebeck HW, Jager B, et al. Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Derm Venereol 2005; 85: 27-32.
22. Schmid-Ott G, Burchard R, Niederauer HH, et al. [Stigmatization and quality of life of patients with psoriasis and atopic dermatitis] 22. Hautarzt 2003; 54: 852-857.
23. Perrott SB, Murray AH, Lowe J, Ruggiero KM,. The personal-group discrimination discrepancy in persons living with psoriasis. Basic Appl Social Psychol 2000; 22: 57-67.
24. Zachariae R, Zachariae H, Blomqvist K, et al. Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers. J Eur Acad Dermatol Venereol 2004; 18: 27-36.
25. Müller H, Brockow T, Franke A, et al. Construct Validity of the Questionnaire on Experience with Skin Complaints (Short Form). J Psychol Assess 2007; 23: 176-184.
26. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
27. Ware JE, Kosinski M, Dewey JE, Gandek B,. How to Score and Interpret Single-Item Health Status Measures: A Manual for Users of the SF-8 Health Survey. Quality Metric Inc, Lincoln, RI, 2001.
28. Bullinger M,. Erfassung der gesundheitsbezogenen Lebensqualität mit dem SF-36-Health Survey. Bundesgesundheitsbl -Gesundheitsforsch- Gesundheitsschutz 2000; 43: 190-197.
29. Cohen J,. A power primer. Psychol Bull 1992; 112: 155-159.
30. Baron RM, Kenny DA,. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986; 51: 1173-1182.